Заключение

В последнее десятилетие был сделан существенный вклад в понимание нейропатологии и механизмов клеточных и биохимических нарушений, связанных с БА. Одновременно с этим были предприняты шаги к разработке моделей этого заболевания на животных.

Литература

Айрапетянц М.Г., Яковлев А.А., Лазарева Н.А. и др. Исследование механизмов, опосредующих гибель нейронов, при хроническом стрессе у крыс // Нейрохимия. 2006. Т 23. № 2. С. 136-142.

Андреева Н.Г., Обухов Д.К., Демьяненко Г.П., Каменская В.Г Морфология нервной системы.

Аниол В.А., Степаничев М.Ю. Оксид азота (II) и гамма-аминомасляная кислота как регуляторы нейрогенеза в мозге взрослых млекопитающих при моделировании судорожной активности // Нейрохимия. 2007. Т 24. № 4. С. 279-289.

Гасанов Г.Г., Меликов Э.М. Нейрохимические механизмы гиппокампа, тета-ритм и поведение. М.: Наука, 1986. С. 184.

Гордон Р.Я., Макарова Е.Г., Подольский И.Я. и др. Нарушение белкового синтеза - раннее проявление действия амилоида-Р в нейронах // Нейрохимия. 2012. Т 29. № 2. С. 139-150.

Манухина Е.Б., Горячева А.В., Барсков И.В. и др. Предупреждение нейродегенеративного повреждения мозга крыс при экспериментальной болезни Альцгеймера с помощью адаптации к гипоксии // Рос. физиол. журнал им. И.М. Сеченова. 2009. Т 95. № 7. С. 706-715.

Митрохина О.С., Степаничев М.Ю., Лазарева Н.А и др. Влияние интрацеребровентрикулярного введения фрагмента (25-35) бета-амилоидного пептида на перекисное окисление липидов в отделах мозга и крови крыс // Докл. РАН. 1999. Т 368. С. 711-713.

Моисеева Ю.В., Онуфриев М.В., Лазарева Н.А., Степаничев М.Ю., Гуляева Н.В. Свободнорадикальные механизмы септо-гиппокампальной нейродегенерации, вызванной холинотоксином AF64A у крыс in vivo // Нейрохимия. 2001. Т 18. С. 287-289.

Муганцева Е.А., Подольский И.Я. Центральное введение амилоидного Р-пептида (25-35) и индивидуальные различия когнитивного поведения у крыс // ЖВНД. 2009. Т 59. № 5. С. 616-621.

Отмахов Н.А. Нейрональная сеть гиппокампа // Успехи физиол. наук. 1993. Т 24. № 4. С. 79-101.

Пшенникова М.Г., Попкова Е.В., Хоменко И.П и др. Устойчивость к нейродегенеративному повреждению мозга у крыс Август и Вистар // Бюлл. эксперим. биол. мед. 2005. Т 139. С. 540-542.

Степаничев М.Ю., Лазарева Н.А., Онуфриев М.В. и др. Влияние введения фрагмента (25-35) Р-амилоидного пептида на поведение крыс // ЖВНД. 1997. Т 47. С. 597-600.

СтепаничевМ.Ю., ОнуфриевМ.В., Митрохина О.С. и др. Нейрохимические, поведенческие и нейроморфологические эффекты центрального введения бета-амилоидного пептида (25-35) у крыс // Нейрохимия.

Степаничев М.Ю., Здобнова И.М., Зарубенко И.И., Лазарева Н.А., Гуляева Н.В. Исследование эффектов центрального введения Р-амилоидного пептида (25-35): патоморфологические изменения в гиппокампе и нарушение пространственной памяти // ЖВНД. 2004а. Т 54. С. 705-711.

Степаничев М.Ю., Моисеева Ю.В., Лазарева Н.А., Гуляева Н.В. Исследование эффектов фрагмента (25-35) Р-амилоидного пептида на поведение крыс в радиальном лабиринте // ЖВНД. 2004б. Т 54. С. 382-389.

Степаничев М.Ю., Флегонтова О.В., Лазарева Н.А., Егорова Л.К., Гуляева Н.В. Влияние противовоспалительного цитокина интерлейкина-4 на нейродегенерацию у крыс, вызванную бета-амилоидным пептидом // Нейрохимия. 2006а. Т. 23. № 1. С. 67-72.

Степаничев М.Ю., Онуфриев М.В., Моисеева Ю.В. и др. Влияние фактора некроза опухоли-альфа и бета- амилоидного пептида (25-35) на показатели свободнорадикального окисления и активность каспазы-3 в мозге крыс // Нейрохимия. 2006б. Т 23. № 3. С. 217- 222.

СтепаничевМ.Ю., Либе М.Л., Чернышевская И.А., Мойсеенок А.Г., Гуляева Н.В. Экспрессия НАДФН- диафоразы в мозге крыс в отдаленные сроки после введения холинотоксина AF64A // Нейрохимия. 2007. Т. 24. С. 161-165.

Степаничев М.Ю., Моисеева Ю.В., Лазарева Н.А., Онуфриев М.В., Гуляева Н.В. Изменения пролиферации клеток в субвентрикулярной зоне мозга у взрослых крыс при введении Р-амилоидного пептида (25-35). Морфология. 2009. Т 135. № 1. С. 13-16.

Степанов И.И., Кузнецова Н.Н., Климентьев Б.И., Сапронов Н.С. Влияние интрацеребровентрику- лярного введения бета-амилоида на динамику обучения у крыс Вистар и нелинейных крыс // Росс. физиол. журнал. 2006. Т 92. С. 449-460.

Тишкина А.О., Левшина И.П., Лазарева Н.А. и др. Хронический стресс вызывает неапоптотическую гибель нейронов в гиппокампе крыс // Докл. РАН. 2009. Т 428. № 1. С. 130-134.

Abe E., Murai S., Masuda Y., Saito H., Itoh T. Alpha-sialyl cholesterol reverses AF64A-induced deficit in passive avoidance response and depletion of hippocampal acetylcoline in mice // Br.

Akiyama H., Barger S., Barnum S. et al. Neuroinflammation Working Group. Inflammation and Alzheimer’s disease // Neurobiol. Aging. 2000. Vol. 21. P. 383-421.

Arendt T., Holzer M., Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer’s disease // J. Neural. Transm. 1998. Vol. 105. P. 949-60.

Arias C., Montiel T., Quiroz-Baez R., Massieu L. beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer’s disease // Exp. Neurol. 2002. Vol. 176. P. 163-174.

Bailey E.L., OverstreetD.H., Crocker A.D. Effects of intrahippocampal injections of the cholinergic neurotoxin AF64A on open-field activity and avoidance learning in the rat // Behav. Neural Biol. 1986. Vol. 45. P. 263-274.

Baxter M.G., Bucci D.J., Gorman L.K., Wiley R.G., Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats // Behav. Neurosci. 1995. Vol. 109. № 4. P. 714-22.

Baxter M.G., Bucci D.J., Sobel T.J., Williams M.J., Gorman L.K., Gallagher M. Intact spatial learning following lesions of basal forebrain cholinergic neurons // Neuroreport. 1996. Vol. 7. № 8. P. 1417-20.

Benraiss A., Chmielnicki E., Lerner K. et al. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain // J. Neurosci. 2001. Vol. 21. P. 6718-6731.

Berrard S., Varoqui H., Cervini R. et al. Coregulation of two embedded gene products, choline acetyltransfer- ase and the vesicularacetylcholine transporter // J. Neurochem. 1995. Vol. 65. № 2. P. 939-942.

Boekhoorn K., Joels M., Lucassen P.J. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus // Neurobiol. Dis.

Braak H., Braak E. Neuropathological staging of Alzheimer-related changes // Acta. Neuropathol. 1991. Vol. 82. P. 239-259.

Brandeis R., Pittel Z., Lachman C. et al. AF64A-induced cholinotoxicity: Behavioral and biochemical correlates // Alzheimer’s and Parkinson’s Disease: Strategies for Research and Development. Ed. A. Fisher et al. NY: Plenum Press, 1986. P. 469-478.

Brown N.H. Integrins as mediators of morphogenesis in Drosophila // Dev. Biol. 2000. Vol. 223. P. 1-16.

Chen S.Y., Harding J.W., Barnes C.D. Neuropathology of synthetic beta-amyloid peptide analogs in vivo // Brain Res. 1996a. Vol. 715. P. 44-50.

Chen S.Y., Wright J.W., Barnes C.D. The neurochemical and behavioral effects of beta-amyloid peptide (2535) // Brain Res. 1996b. Vol. 720. P. 54-60.

Cheng A., Wang S., Cai J. et al. Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain // Dev. Biol. 2003. Vol. 258. P. 319-333.

Christensen R., Marcussen A.B., Wortwein G. et al. Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels // Exp. Neurol. 2008. Vol. 210. P. 164-171.

Chrobak J.J., Hanin I., Schmechel D.E., Walsh T.J. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates // Brain Res. 1988. Vol. 463. P. 107-117.

Chrobak J.J., Spates M.J., Stackman R.W., Walsh T.J. Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A) // Brain Res. 1989. Vol. 504. P. 269-275.

Coyle J.T., Price D.L., DeLong M.R. Alzheimer’s disease: a disorder of central cholinergic innervation // Science. 1983. V 219. P 1184-1190.

Dagyte G., Van der Zee E.A., Postema F. et al. Chronic but not acute foot-shock stress leads to temporary suppression of cell proliferation in rat hippocampus // Neuroscience.

Deisseroth K., Singla S., Toda H. et al. Excitation-neurogenesis coupling in adult neural stem/progenitor cells // Neuron. 2004. Vol. 42. P. 535-552.

Deisseroth K., MalenkaR.C. GABA excitation in the adult brain: a mechanism for excitation- neurogenesis coupling // Neuron. 2005. Vol. 47. P. 775-777.

Delobette S., Privat A., Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat // Eur. J. Pharmacol. 1997. Vol. 319. P. 1-4.

Dineley K.T., KayedR., Neugebauer V., Fu Y., Zhang W., Reese L.C. et al. Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice // J. Neurosci. Res. 2010. Vol. 88. P. 2923-32.

Ding Q., Markesbery W.R., Chen Q., LiF., Keller J.N. Ribosome dysfunction is an early event in Alzheimer’s disease // J. Neurosci. 2005. Vol. 25. P. 9171-9175.

Doetsch F., Petreanu L., Caille I. et al. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells // Neuron. 2002. Vol. 36. P. 1021-1034.

Dudas B, Hanin I, Rose M, Wulfert E. Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid // Neurobiol. Dis. 2004. Vol. 15. № 2. P. 262-268.

Emerich D.F., Black B.A., Kesslak J.P. et al. Transplantation of fetal cholinergic neurons into the hippocampus attenuates the cognitive and neurochemical deficits induced by AF64A // Brain Res. Bull. 1992. Vol. 28. P. 219-226.

Emerich D.F., Walsh T.J. Ganglioside AGF2 promotes task- specific recovery and attenuates the cholinergic hypofunction induced by AF64A // Brain Res. 1990. Vol. 572. P. 299-307.

Estrada C., Murillo-Carretero M. Nitric oxide and adult neurogenesis in health and disease // Neuroscientist. 2005. Vol. 11. P 294-307.

Eva C., Fabrazzo M., Costa E. Changes of cholinergic, noradrenergic and serotonergic synaptic transmission indices by ethylcholine aziridinium ion (AF64A) infused intraventricularly // J. Pharmacol. Exp. Ther. 1987. Vol. 222. P 181-186.

Fishman K., Baure J., Zou Y. et al. Radiation-induced reductions in neurogenesis are ameliorated in mice deficient in CuZnSOD or MnSOD // Free Radic. Biol. Med. 2009. Vol. 47. P 1459-1467.

Flood J.F., Morley J.E., Roberts E. Amnesic effects in mice of four synthetic peptides homologous to amyloid P protein from patients with Alzheimer disease // Proc. Natl. Acad. Sci. USA. 1991. Vol. 88. P 3363-3366.

Flood J.F., Morley J.E., Roberts E. An amyloid P protein fragment, AP[12-28], equipotently impairs posttraining memory processing when injected into different limbic system structures // Brain Res. 1994. Vol. 663. P 271-276.

Francis P.T., Simus N.R., Procter A.W., Bowen D.M. Cortical pyramidal neurone loss may cause glutama- tergic hypoactivity and cognitive impairment in Alzheimer’s disease: investigative and therapeutic perspectives // J. Neurochem. 1993. Vol. 60. P 1589-1604.

Frautschy S.A., Cole G. M., Baird A. Phagocytosis and deposition of vascular beta-amyloid in rat brains

injected with Alzheimer’s beta-amyloid // Am. J. Pathol. 1992. Vol. 140. P. 1389-1399.

Fuchs E., Flugge G., Ohl F et al. Psychosocial stress, glucocorticoids, and structural alterations in the tree shrew hippocampus // Physiol. Behav. 2001. Vol. 73. P. 285-291.

Games D., Khan K.M., Soriano F.G. et al. Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain // Neurobiol. Aging. 1992. Vol. 13. P. 569-576.

Geula C., Wu C.-K., Saroff D. et al. Aging renders the brain vulnerable to amyloid b-protein neurotoxicity // Nat. Med. 1998. Vol. 4. P. 827- 831.

Giovannelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides P-(1- 40) and P-(25-35) injections into the rat nucleus basalis // Neuroscience. 1995. Vol. 66. P. 781-792.

Gomez-Cabrera M.C., Domenech E., Vina J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training // Free Radic. Biol. Med. 2008. Vol. 44. P. 126-131.

Gulyaeva N.V., Lazareva N.A., Libe M.L. et al. Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A) // Brain Res. 1996. Vol. 726. P. 174-180.

Gulyaeva N.V., Victorov I.V., Stepanichev M.Yu. et al. Intracerebroventricular administration of beta-amyloid peptide (25-35) induces oxidative stress and neurodegeneration in rat brain // Progress in Alzheimer’s and Parkinson’s diseases. Eds. A. Fisher et al. NY: Plenum Press, 1997. P. 89-98.

Gulyaeva N.V., Victorov I.V., Stepanichev M.Yu. et al. Intracerebroventricular administration of beta-amyloid peptide (25-35) induces oxidative stress and neurodegeneration in rat brain // Progress in Alzheimer’s and Parkinson’s diseases. Eds. A. Fisher et al. NY: Plenum Press. 1998. P. 89-98.

Hamilton L.K., Joppe S.E., Cochard M.L., Fernandes K.J. Aging and neurogenesis in the adult forebrain: what we have learned and where we should go from here // Eur. J. Neurosci. 2013. Vol. 37. № 12. P. 1978-1986.

Hanin I. The AF64A model of cholinergic hypofunction: an update // Life Sci. 1996. Vol. 58. P. 1955-1964.

Hanin I. Molecular mechanisms of AF64A toxicity in the cholinergic neuron // Progress in Alzheimer’s and Parkinson’s diseases. Eds. A. Fisher et al. NY, London: Plenum press, 1997. P. 675-680.

Hanin A., FisherA., Hortnagl H. et al. Ethylcholine aziridinium (AF64A; ECMA) and other potential cholinergic neuron-specific neurotoxins // Psychopharmacology: The Third Generation of Progress. Ed. H.Y. Meltzer. NY: Raven press, 1987. P. 341-349.

Harkany T., O’Mahony S., Kelly J.P. et al. Beta-amyloid(Phe(SO3H)24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation // Behav. Brain Res., 1998. Vol. 90. P. 133-145.

Harkany T., Mulder J., Sasvari M. et al. N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity // Neurobiol. Dis. 1999. Vol. 6. P. 109-121.

Haughey N.J., Liu D., Nath A. et al. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer’s disease // Neuromolec. Med. 2002a. Vol. 1. P. 125-135.

Haughey N.J., Nath A., Chan S.L. et al. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer’s disease // J. Neurochem. 2002b. Vol. 83. P. 1509-1524.

Heine VM., Zareno J., Maslam S. et al. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression // Eur. J. Neurosci. 2005. Vol. 21. P. 13041314.

Hickman S.E., Allison E.K., ElKhoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice // J. Neurosci. 2008. Vol. 28. P. 8354-8360.

Hoozemans J.J., Bruckner M.K., Rozemuller A.J. et al. Cyclin D1 and cyclin E are co-localized with cyclooxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex // J. Neuropathol. Exp. Neurol. 2002. Vol. 61. P. 678-688.

Icard-Liepkalns C., Berrard S., Faucon Biguet N. et al. Tyrosine hydroxylase regulation in neurotransmission and neuroplasticity // J. Physiol. Paris. 1993. Vol. 87. № 3. P. 153-157.

Jaffrey S.R., Erdjument-Bromage H., Ferris C.D. et al. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide // Nat. Cell Biol. 2001. Vol. 3. P. 193-197.

Jarrard L.E., Levy A., Meyerhoff J.L., Kant G.J. Intracerebral injections of AF64A: an animal model of Alzheimer’s disease? // Ann. NY Acad. Sci. 1985. Vol. 444. P. 520-522.

Jin C.H., Shin E.J., Park J.B., Jang C.G. et al. Fustin flavonoid attenuates beta-amyloid (1-42)-induced learning impairment // J. Neurosci. Res. 2009. Vol. 87. P. 658-670.

Jin K., Galvan V., Xie L. et al. Enhanced neurogenesis in Alzheimer’s disease transgenic (PDGF-APPSw,Ind) mice // Proc. Natl. Acad. Sci. USA. 2004a. Vol. 101. P 13363-13367.

Jin K., Peel A. L., Mao X. O. et al. Increased hippocampal neurogenesis in Alzheimer’s disease // Proc. Nat. Acad. Sci. USA. 2004b. Vol. 101. № 1. P. 343-347.

Kempermann G., Kuhn H.G., Gage F.H. Experience-induced neurogenesis in the senescent dentate gyrus // J. Neurosci. 1998. Vol. 18. P. 3206-3212.

Kempermann G., Gast D., Gage F.H. Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment // Ann. Neurol. 2002. Vol. 52. V 135-143.

Klementiev B., Novikova T., Novitskaya V. et al. A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35 // Neuroscience. 2007. Vol. 145. P. 209-224.

Kowall N., McKee A., Yankner B., Beal M.F. In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment // Neurobiol. Aging. 1992. Vol. 13. P. 537-542.

Krstic D., Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease // Nat. Rev. Neurol. 2013. Vol. 9. P. 25-34.

Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation // J. Neurosci. 1996. Vol. 16. P. 2027-2033.

Kuhn H.G., Winkler J., Kempermann G. et al. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain // J. Neurosci. 1997. Vol. 17. P. 5820-5829.

Kuwagata Y, Inoue H. Effects of estrogen on AF64A-induced apoptosis in NG108-15 cells // Brain Res. 2009. Vol. 1297. P. 9-16.

Lautenshlager M., Arnswald A., Freyer D. et al. The AF64A Model of cholinergic hypofunction: Role of nitric oxide in AF64A-mediated neurodegeneration // Progress in Alzheimer’s and Parkinson’s Diseases. / Eds. Fisher A. et al. NY, London: Plenum press, 1997. P. 681-686.

Lautenschlager M., Onufriev M.V., Gulyaeva N.V et al. Role of nitric oxide in the ethylcholine aziridinium model of delayed apoptotic neurodegeneration in vivo and in vitro // Neuroscience. 2000. Vol. 97. P. 383-393.

Lazarov O., Mattson M.P., Peterson D.A., Pimplikar S.W., van Praag H. When neurogenesis encounters aging and disease. // Trends Neurosci. 2010. Vol. 33. № 12. P. 569-579.

Lazo O.M., Mauna J.C., Pissani C.A., Inestrosa N.C., Bronfman F.C. Axotomy-induced neurotrophic withdrawal causes the loss of phenotypic differentiation and downregulation of NGF signalling, but not death of septal cholinergic neurons // Mol. Neurodegener. 2010. Vol. 5. P. 5.

LiX., ZuoP. Effects of Abeta25-35 on neurogenesis in the adult mouse subventricular zone and dentate gyrus // Neurol. Res. 2005. Vol. 27. P 218-222.

Li B., Yamamori H., Tatebayashi Y. et al. Failure of neuronal maturation in Alzheimer disease dentate gyrus // J. Neuropathol. Exp. Neurol. 2008. Vol. 67. P. 78-84.

Lie D.C., SongH., Colamarino S.A. et al. Neurogenesis in the adult brain: new strategies for central nervous system diseases // Annu. Rev. Pharmacol. Toxicol. 2004. Vol. 44. P 399-421.

Lim D.K., Oh Y.H., Kim H.S. Impairments of learning and memory following intracerebroventricular administration of AF64A in rats // Arch. Pharm. Res. 2001. Vol. 24. № 3. P 234-239.

Lopez-Toledano M.A., Shelanski M.L. Neurogenic effect of P-amyloid peptide in the development of neural stem cells // J. Neurosci. 2004. Vol. 24. P 5439-5444.

Lorens S.K., Kindel G, Dong X.W. et al. Septal choline acetyltransferase immunoreactive neurons: dose- dependent effects ofAF64A // Brain Res. Bull. 1991. Vol. 26. P. 965-971.MalikB., CurraisA., Soriano S. Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer’s disease // J. Neurochem. 2008. Vol. 106. P 912-6.

Mallet J., Houhou L., Pajak F., Oda Y., Cervini R., Bejanin S., Berrard S. The cholinergic locus: ChAT and VAChT genes. // J. Physiol. Paris. 1998. Vol. 92. № 2. P 145-147.

Mannisto P.T., Tuomainen P., Kutepova O. et al. Effects of bilateral cholinotoxin infusions on the behavior and brain biochemistry oh the rats // Pharmacol. Biochem. Behav. 1994. Vol. 49. P. 33-40.

Matarredona E.R., Murillo-Carretero M., Moreno-Lopez B., Estrada C. Nitric oxide synthesis inhibition increases proliferation of neural precursors isolated from the postnatal mouse subventricular zone // Brain Res. 2004. Vol. 995. P 274-284.

Maurice T., Lockhart B., Privat A. Amnesia induced in mice by centrally administered b-amyloid peptides involves cholinergiic dysfunction // Brain Res. 1996. Vol. 706. P. 181-189.

Maurice T., Su T.P., Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-am- yloid peptide-induced amnesia in mice through a common mechanism // Neuroscience. 1998. Vol. 83. P. 413-428.

Mazur-Kolecka B., GolabekA., Nowicki K. et al. Amyloid-beta impairs development of neuronal progenitor cells by oxidative mechanisms // Neurobiol. Aging. 2006. Vol. 27. P. 1181-1192.

McDonald M.P., Overmier J.B. Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer’s disease // Neurosci. Biobehav. Rev. 1998. Vol. 22. P. 99-120.

McDonald M.P., Dahl E.E., Overmier Y.B. et al. Effects of an exogenous P-amyloid peptide on retention for apatial learning // Behav. Neural. Biol. 1994. Vol. 62. P. 60-67.

McDonald M.P., Dahl E.E., Overmier Y.B. et al. Reversal of P-amyloid-induced retention deficit after exposure to training and state cues // Neurobiol. Learn. Memory. 1996. Vol. 65. P. 35-47.

Miyamoto M., Hirai K., Takahashi H. et al. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents // Eur. J. Pharmacol. 1993. Vol. 238. P. 181-189.

Montiel T., Quiroz-Baez R., Massieu L., Arias C. Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants // Exp. Neurol. 2006. Vol. 200. P. 496-508.

Moreno-Lopez B., Noval J.A., Gonzalez-Bonet L., Estrada C. Morphological bases for a role of nitric oxide in adult neurogenesis // Brain Res. 2000. Vol. 869. P. 244-250.

Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer’s disease // J. Neurosci. 2007. Vol. 27. P. 6859-67.

Murillo-Carretero M., Ruano M.J., Matarredona E.R. et al. Antiproliferative effect of nitric oxide on epidermal growth factor-responsive human neuroblastoma cells // J. Neurochem. 2002. Vol. 83. P. 119-131.

Nabeshima T., Nitta A. Memory impairment and neuronal dysfunction induced by P-amyloid protein in rats // Toh. J. Exp. Med. 1994. Vol. 174. P. 241-249.

Nitta A., Iton A., Hasegawa T., Nabeshima T. P-amyloid-protein-induced Alzheimer”s disease animal model // Neurosci. Lett. 1994. Vol. 28. P. 63-66.

Opello K.D., Stackman R.W., Ackerman S., Walsh T.J. AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task // Physiol. Behav. 1993. Vol. 54. P. 1227-1233.

Peng S., Garzon D.J., Marchese M. et al. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer’s disease // J. Neurosci. 2009. Vol. 29. P. 9321-9329.

Peunova N., Scheinker V., Cline H., Enikolopov G. Nitric oxide is an essential regulator of cell proliferation in Xenopus brain // J. Neurosci. 2001. Vol. 21. P. 8809-8818.

Pike C.J., Walencewicz-Wasserman A. J., Kosmoski J. et al. Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity // J. Neurochem. 1995. Vol. 64. P. 253-262.

Qiu W.Q., Ye Z., Kholodenko D. et al. Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells // J. Biol. Chem. 1997. Vol. 272. P. 6641-6646.

Radak Z., Kumagai S., Taylor A.W. et al. Effects of exercise on brain function: role of free radicals // Appl. Physiol. Nutr Metab. 2007. Vol. 32. P 942-946.

Radak Z., Hart N., Sarga L. et al. Exercise plays a preventive role against Alzheimer’s disease // J. Alzheim- ers Dis. 2010. Vol. 20. P 777-783.

Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the mammalian central nervous system // Science. 1992. Vol. 255. P 1707-1710.

Rinner W.A., Pifl C., Lassmann H., Hortnagl H. Induction of apoptosis in vitro and in vivo by the cholinergic neurotoxin ethylcholine aziridinium // Neuroscience. 1997. Vol. 79. P 535-542.

Rivas-Arancibia S., Guevara-Guzman R., Lopez-Vidal Y. et al. Oxidative stress caused by ozone exposure induces loss of brain repair in the hippocampus of adult rats // Toxicol. Sci. 2010. Vol. 113. P. 187-197.

Rogers J., Lue L. F. Microglial chemotaxis, activation, and phagocytosis of amyloid P-peptide as linked phenomena in Alzheimer’s disease // Neurochem. Int. 2001. Vol. 39. P. 333-340.

Rossner S., Hartig W., Schliebs R., Bruckner G., Brauer K., Perez-Polo J.R., Wiley R.G., Bigl V 192IgG- saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei // J. Neurosci Res. 1995. Vol. 41. № 3. P. 335-46.

Rush D.R., Aschmies S., Merriman M.C. Intracerebral P-amyloid (25-35) produces tissue damage: is it neurotoxic? // Neurobiol. Aging. 1992. Vol. 13. P. 591-594.

Santacana M., Uttenthal L.O., Bentura M.L. et al. Expression of neuronal nitric oxide synthase during embryonic development of the rat cerebral cortex // Brain Res. Dev. Brain. Res. 1998. V 111. P. 205-222.

Seeger G., Hartig W., Rossner S. et al. Electron microscopic evidence for microglial phagocytic activity and cholinergic cell death after administration of the immunotoxin 192IgG-saporin in rat // J. Neurosci Res. 1997. Vol. 48. № 5. P. 465-76.

Shan X., Chang Y., Lin C.L. Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression // FASEB J. 2007. Vol. 21. P. 2753-2764.

Sigurdsson E.M., Hejna M.J., Lee J.M., Lorens S.A. beta-Amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer- 344 rats: behavioral, neurochemical and histological effects // Behav. Brain Res. 1995. Vol. 72. P. 141-156.

Sigurdsson E.M., Lorens S.A., Hejna M.J. et al. Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats // Neurobiol. Aging. 1996. Vol. 17. P. 893-901.

Sigurdsson E.M., Lee J.M., Dong X.W. et al. Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects // Neuro- biol. Aging. 1997a. Vol. 18. P. 591-608.

Sigurdsson E.M., Lee J.M., Dong X.W. et al. Laterality in the histological effects of injections of amyloid- beta 25-35 into the amygdala of young Fischer rats // J. Neuropathol. Exp. Neurol. 1997b. Vol. 56. P. 714-725.

Simon H.U., Haj-Yehia A., Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction // Apoptosis. 2000. Vol. 5. P. 415-418.

Sotthibundhu A., Li Q.X., Thangnipon W., Coulson E.J. Abeta(1-42) stimulates adult SVZ neurogenesis through the p75 neurotrophin receptor // Neurobiol. Aging. 2009. Vol. 30. P. 1975-1985.

Stranahan A.M., Mattson M.P. Recruiting adaptive cellular stress responses for successful brain ageing // Nat. Rev. Neurosci. 2012. Vol. 13. P. 209-216.

Stein-Behrens B., Adams K., Yeh M., Sapolsky R. Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat // Neurobiol. Aging. 1992. Vol. 13. P. 577-579.

Stepanichev M.Yu., Moiseeva Yu.V., Lazareva N.A. et al. Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats // Brain Res. Bull. 2003a. Vol. 61. P. 197-205.

Stepanichev M.Yu., Zdobnova I.M., Yakovlev A.A. et al. Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35) // J. Neurosci. Res. 2003b. Vol. 71. P. 110-120.

Stepanichev M.Yu., Zdobnova I.M., Zarubenko I.I. et al. Amyloid-beta(25-35)-induced memory impairments correlate with cell loss in rat hippocampus // Physiol. Behav. 2004. Vol. 80. P. 647-655.

Stepanichev M., Zdobnova I., Zarubenko I. et al. Differential effects of tumor necrosis factor-alpha co-administered with amyloid beta-peptide (25-35) on memory function and hippocampal damage in rat // Behav. Brain Res. 2006. Vol. 175. P. 352-361.

Stepanichev M.Yu., Onufriev M.V., Yakovlev A.A. et al. Amyloid-beta (25-35) increases activity of neuronal NO-synthase in rat brain // Neurochem. Int. 2008. Vol. 52. P. 1114-1124.

Stepanichev M., Lazareva N., Tukhbatova G., Salozhin S., Gulyaeva N. Transient disturbances in contextual fear memory induced by AP(25-35) in rats are accompanied by cholinergic dysfunction // Behav Brain Res. 2014. Vol. 259. P 152-157.

Streit W.J., Mrak R.E. Griffin W.S.T. Microglia and neuroinflammation: a pathological perspective // J. Neuroinflammation. 2004. Vol. 1. P. 14.

Sweeney W., Luedtke J., McDonald M. P., Overmier J.B. Intrahippocampal P-amyloid impairs win-shift radial mase performance in rats // Neurobiol. Learn. Memory. 1997. Vol. 68. P. 97-101.

Tang Y., Yamada K., Kanou Y. et al. Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of beta-amyloid in rats // Brain Res. Mol. Brain Res. 2000. Vol. 80. P. 188-197.

Terranova J.P., Kan J.P., Storme J.J. et al. Administration of amyloid beta-peptides in the rat medial septum causes memory deficits: reversal by SR 57746A, a non-peptide neurotrophic compound // Neurosci. Lett. 1996. Vol. 213. P. 79-82.

Tozuka Y., Fukuda S., Namba T. et al. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells // Neuron. 2005. Vol. 47. P. 803-815.

Tsunekawa H, Noda Y, Mouri A, Yoneda F, Nabeshima T. Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35) // Behav. Brain Res. 2008. Vol. 190. P. 224-232.

Urani A, Romieu P, Roman FJ, Yamada K, Noda Y, Kamei H et al. Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein // Eur J Pharmacol. 2004. Vol. 486. P. 151-161.

Van Praag H., Christie B.R., Sejnowski T.J., Gage F.H. Running enhances neurogenesis, learning, and longterm potentiation in mice // Proc. Natl. Acad. Sci. USA. 1999a. Vol. 96. P. 13427-13431.

Van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus // Nat. Neurosci. 1999b. Vol. 2. P. 266-270.

VarvelN.H., Bhaskar K., PatilA.R., Pimplikar S.W., Herrup K., Lamb B.T. Abeta oligomers induce neuronal cell cycle events in Alzheimer’s disease // J. Neurosci. 2008. Vol. 28. P. 10786-10793.

Virok D.P., Simon D., Bozso Z., Rajko R., Datki Z., Balint E., Szegedi V., Janaky T., Penke B., Fulop L. Protein array based interactome analysis of amyloid-P indicates an inhibition of protein translation // J. Proteome Res. 2011. Vol. 10. P. 1538-1547.

Von Linstow RoloffE., PlattB., Riedel G. No spatial working memory deficit in beta-amyloid-exposed rats. A longitudinal study // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2002. Vol. 26. P. 955-970.

Waite J.J., Wardlow M.L., Chen A.C., Lappi D.A., Wiiley R.G., Thal L.J. Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192IgG-saporin // Neurosci. Lett. 1994. Vol. 169. P. 154-158.

Waite, J.J., Chen, A.D., Wardlow, M.L., Wiley, R.G., Lappi, D.A., Thal, L.J. 192 Immunoglobulin G-saporin produces graded behavioural and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells // Neuroscience. 1995. Vol. 65. P. 463-476.

Walsh T.J., Tilson H.A., DeHaven D.L. et al. AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocsmpus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat // Brain Res. 1984. Vol. 321. P. 91-102.

Walsh T.J., Opello K.D. The use ofAF64A to model Alzheimer’s disease // Animal Models of Toxin-lnduced Neurological Disorders. Eds. M. Woodruff, A. Nonneman. NY: Plenum Press, 1994, P. 259-279.

Walsh T.J. Models of cholinergic degeneration: AF64A and 192-IgG-saporin // Progress in Alzheimer’s and Parkinson’s diseases. Eds. A. Fisher et al. NY, London: Plenum press, 1997. P. 667-674.

Wang D., Noda Y., Zhou Y., Mouri A., Mizoguchi H., Nitta A. et al. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems // Neuropsychopharmacology. 2007. Vol. 32. P. 1261-1271.

Weldon D.T., Rogers S.D., Ghilardi J.R. et al. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo // J. Neurosci. 1998. Vol. 18. P. 2161-2173.

Wiley R.G., Oeltmann T.N., Lappi D.A. Immunolesioning: selective destruction of neurons using immuno- toxin to rat NGF receptor // Brain Res. 1991. Vol. 562. P. 149-153.

Winkler J., Thal L.J., Gage F.H., Fisher L.J. Cholinergic strategies for Alzheimer’s disease // J. Mol. Med. 1998. Vol. 76. P. 555-567.

Wortwein G., Stackman R.W., Walsh T.J. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A // Exp. Neurol. 1994. Vol. 125. P. 15-21.

Yamada K., Nabeshima T. Animal models of Alzheimer’s disease and evaluation of anti-dementia drugs // Pharmacol. Ther. 2000. Vol. 88. P. 93-113.

Yamaguchi Y., Kawashima S. Effects of b-amyloid-(25-35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat // Eur. J. Pharmacol. 2001. Vol. 412. P. 265-272.

Yamamoto T., Jin J., Watanabe S. Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs // Behav. Brain Res. 1997. Vol. 83. № 1-2. P. 57-62.

Yang Y., Mufson E.J., Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease // J. Neurosci. 2003. Vol. 23. P. 2557-63.

Yehuda S., Carraso R.L., Mostofsky D.I. Essential fatty acid preparation (SR-3) rehabilitates learning deficits induced by AF64A and 5:7-DHT // Neuroreport. 1995. Vol. 6. P 511-515.